‘Le Roi est mort, vive le Roi’: new roles of radiotherapy in the treatment of lymphomas in combination with immunotherapy.

immunotherapy (IT), including checkpoint inhibitors (CIs) and Chimeric Antigen Receptor T cell therapy (CAR-T) revolutionized the treatment of relapsing or refractory (r/r) lymphoma. Several preliminary experiences evaluated concomitant administration of radiotherapy and IT.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 10, 2021 Category: Hematology Authors: Andrea Emanuele Guerini, Andrea Riccardo Filippi, Alessandra Tucci, Gabriele Simontacchi, Alessandro Re, Annamaria Guaineri, Vittorio Morelli, Paolo Borghetti, Luca Triggiani, Ludovica Pegurri, Sara Pedretti, Giulia Volpi, Luigi Spiazzi, Stefano Maria Mag Source Type: research